{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["CIPN", "ozone", "pain treatment"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "36982352", "DateCompleted": {"Year": "2023", "Month": "03", "Day": "30"}, "DateRevised": {"Year": "2023", "Month": "03", "Day": "31"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2023", "Month": "03", "Day": "09"}], "ELocationID": ["5279", "10.3390/ijms24065279"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "24", "Issue": "6", "PubDate": {"Year": "2023", "Month": "Mar", "Day": "09"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Ozone in Chemotherapy-Induced Peripheral Neuropathy-Current State of Art, Possibilities, and Perspectives.", "Abstract": {"AbstractText": ["Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most detrimental toxicity to a patient's quality of life. Pathophysiological mechanisms involved in CIPN pathogenesis are complex, multifactorial, and only partially examined. They are suspected to be associated with oxidative stress (OS), mitochondrial dysfunction, ROS-induced apoptosis, myelin sheath and DNA damage, and immunological and inflammatory processes. Unfortunately, medications commonly used for the management of other neuropathic pain syndromes, including gabapentinoids, opioids, and tricyclic antidepressants (such as desipramine and nortriptyline), do not bring satisfactory results in CIPN. The aim of this review is to evaluate the existing literature on the potential use of medical ozone as a treatment for CIPN. This paper would explore the potential therapeutic benefits of medical ozone. The review would evaluate the existing literature on the use of medical ozone in other contexts, as well as its potential application in treating CIPN. The review would also suggest possible research methods, such as randomized controlled trials, to evaluate the efficacy of medical ozone as a treatment for CIPN. Medical ozone has been used to disinfect and treat diseases for over 150 years. The effectiveness of ozone in treating infections, wounds, and a variety of diseases has been well documented. Ozone therapy is also documented to inhibit the growth of human cancer cells and has antioxidative and anti-inflammatory effects. Due to its ability to modulate oxidative stress, inflammation, and ischemia/hypoxia, ozone may have a potentially valuable effect on CIPN."]}, "AuthorList": [{"Identifier": ["0000-0001-8033-3574"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Oncology and Chemotherapy, Medical University of Lublin, 20-954 Lublin, Poland."}], "LastName": "Szklener", "ForeName": "Katarzyna", "Initials": "K"}, {"Identifier": ["0000-0002-8901-6222"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Oncology and Chemotherapy, Medical University of Lublin, 20-954 Lublin, Poland."}], "LastName": "Rudzi\u0144ska", "ForeName": "Anna", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Oncology and Chemotherapy, Medical University of Lublin, 20-954 Lublin, Poland."}], "LastName": "Juchaniuk", "ForeName": "Pola", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Oncology and Chemotherapy, Medical University of Lublin, 20-954 Lublin, Poland."}], "LastName": "Kaba\u0142a", "ForeName": "Zuzanna", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Oncology and Chemotherapy, Medical University of Lublin, 20-954 Lublin, Poland."}], "LastName": "Ma\u0144dziuk", "ForeName": "S\u0142awomir", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antidepressive Agents, Tricyclic"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Antidepressive Agents, Tricyclic"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["chemically induced", "drug therapy"], "DescriptorName": "Neuralgia"}, {"QualifierName": [], "DescriptorName": "Quality of Life"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ozone"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Smith S.M., Wachter K., Burris H.A., 3rd, Schilsky R.L., George D.J., Peterson D.E., Johnson M.L., Markham M.J., Mileham K.F., Beg M.S., et al. Clinical Cancer Advances 2021: ASCO\u2019s Report on Progress Against Cancer. J. Clin. Oncol. 2021;39:1165\u20131184. doi: 10.1200/JCO.20.03420.", "ArticleIdList": ["10.1200/JCO.20.03420", "33527845"]}, {"Citation": "Liu Y.-Q., Wang X.-L., He D.-H., Cheng Y.-X. Protection against chemotherapy- and radiotherapy-induced side effects: A review based on the mechanisms and therapeutic opportunities of phytochemicals. Phytomedicine. 2021;80:153402. doi: 10.1016/j.phymed.2020.153402.", "ArticleIdList": ["10.1016/j.phymed.2020.153402", "33203590"]}, {"Citation": "Zajaczkowska R., Kocot-Kepska M., Leppert W., Wrzosek A., Mika J., Wordliczek J. Mechanisms of Chemotherapy-Induced Peripheral Neuropathy. Int. J. Mol. Sci. 2019;20:1451. doi: 10.3390/ijms20061451.", "ArticleIdList": ["10.3390/ijms20061451", "PMC6471666", "30909387"]}, {"Citation": "Velasco R., Bruna J. Chemotherapy-induced peripheral neuropathy: An unresolved issue. Neurologia. 2010;25:116\u2013131. doi: 10.1016/S0213-4853(10)70036-0.", "ArticleIdList": ["10.1016/S0213-4853(10)70036-0", "20487712"]}, {"Citation": "Areti A., Yerra V.G., Naidu V., Kumar A. Oxidative stress and nerve damage: Role in chemotherapy induced peripheral neuropathy. Redox Biol. 2014;2:289\u2013295. doi: 10.1016/j.redox.2014.01.006.", "ArticleIdList": ["10.1016/j.redox.2014.01.006", "PMC3909836", "24494204"]}, {"Citation": "Teng C., Cohen J., Egger S., Blinman P.L., Vardy J.L. Systematic review of long-term chemotherapy-induced peripheral neuropathy (CIPN) following adjuvant oxaliplatin for colorectal cancer. Support Care Cancer. 2022;30:33\u201347. doi: 10.1007/s00520-021-06502-4.", "ArticleIdList": ["10.1007/s00520-021-06502-4", "34410459"]}, {"Citation": "Han Y., Smith M.T. Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN) Front. Pharmacol. 2013;4:156. doi: 10.3389/fphar.2013.00156.", "ArticleIdList": ["10.3389/fphar.2013.00156", "PMC3866393", "24385965"]}, {"Citation": "Sisignano M., Baron R., Scholich K., Geisslinger G. Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain. Nat. Rev. Neurol. 2014;10:694\u2013707. doi: 10.1038/nrneurol.2014.211.", "ArticleIdList": ["10.1038/nrneurol.2014.211", "25366108"]}, {"Citation": "Desforges A.D., Hebert C.M., Spence A.L., Reid B., Dhaibar H.A., Cruz-Topete D., Cornett E.M., Kaye A.D., Urits I., Viswanath O. Treatment and diagnosis of chemotherapy-induced peripheral neuropathy: An update. Biomed. Pharmacother. 2022;147:112671. doi: 10.1016/j.biopha.2022.112671.", "ArticleIdList": ["10.1016/j.biopha.2022.112671", "35104697"]}, {"Citation": "Loprinzi C.L., Lacchetti C., Bleeker J., Cavaletti G., Chauhan C., Hertz D.L., Kelley M.R., Lavino A., Lustberg M.B., Paice J.A., et al. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update. J. Clin. Oncol. 2020;38:3325\u20133348. doi: 10.1200/JCO.20.01399.", "ArticleIdList": ["10.1200/JCO.20.01399", "32663120"]}, {"Citation": "Hu L.Y., Mi W.L., Wu G.C., Wang Y.Q., Mao-Ying Q.L. Prevention and Treatment for Chemotherapy-Induced Peripheral Neuropathy: Therapies Based on CIPN Mechanisms. Curr. Neuropharmacol. 2019;17:184\u2013196. doi: 10.2174/1570159X15666170915143217.", "ArticleIdList": ["10.2174/1570159X15666170915143217", "PMC6343206", "28925884"]}, {"Citation": "Bocci V. Biological and clinical effects of ozone. Has ozone therapy a future in medicine? Br. J. Biomed. Sci. 1999;56:270\u2013279.", "ArticleIdList": ["10795372"]}, {"Citation": "Di Paolo N., Bocci V., Gaggiotti E. Ozone therapy. Int. J. Artif. Organs. 2004;27:168\u2013175. doi: 10.1177/039139880402700303.", "ArticleIdList": ["10.1177/039139880402700303", "15112882"]}, {"Citation": "Shoemaker J.M. Ozone Therapy: History, Physiology, Indications, Results. Volume 114 Judith Shoemaker; Nottingham, PA, USA: 2005."}, {"Citation": "Hidalgo-Tall\u00f3n F.J., Torres-Morera L.M., Baeza-Noci J., Carrillo-Izquierdo M.D., Pinto-Bonilla R. Updated Review on Ozone Therapy in Pain Medicine. Front. Physiol. 2022;13:840623. doi: 10.3389/fphys.2022.840623.", "ArticleIdList": ["10.3389/fphys.2022.840623", "PMC8904924", "35283802"]}, {"Citation": "Kirsever E., Kiziltan H.\u015e., Yilmaz R., G\u00fcne\u015f Bayir A.Y.\u015e.E., Ba\u015fib\u00fcy\u00fck M., \u00c7akir F.B., G\u00fcl K., \u015eim\u015fek M., Kiziltepe A., G\u00fcm\u00fc\u015f A., et al. Pain management with Radiotherapy and ozone with high dose vitamin C therapy in a case of bone metastatis of breast cancer patient. J. Radiat. Oncol. Palliation. 2017;1:10\u20131310."}, {"Citation": "Zargaran M., Fatahinia M., Zarei Mahmoudabadi A. The efficacy of gaseous ozone against different forms of Candida albicans. Curr. Med. Mycol. 2017;3:26\u201332. doi: 10.29252/cmm.3.2.26.", "ArticleIdList": ["10.29252/cmm.3.2.26", "PMC5763895", "29354778"]}, {"Citation": "Elvis A.M., Ekta J.S. Ozone therapy: A clinical review. J. Nat. Sci. Biol. Med. 2011;2:66\u201370. doi: 10.4103/0976-9668.82319.", "ArticleIdList": ["10.4103/0976-9668.82319", "PMC3312702", "22470237"]}, {"Citation": "Hidalgo-Tall\u00f3n F.J., Men\u00e9ndez-Cepero S., Vilchez J.S., Rodr\u00edguez-L\u00f3pez C.M., Calandre E.P. Ozone therapy as add-on treatment in fibromyalgia management by rectal insufflation: An open-label pilot study. J. Altern. Complement. Med. 2013;19:238\u2013242. doi: 10.1089/acm.2011.0739.", "ArticleIdList": ["10.1089/acm.2011.0739", "23046293"]}, {"Citation": "Tirelli U., Cirrito C., Pavanello M., Piasentin C., Lleshi A., Taibi R. Ozone therapy in 65 patients with fibromyalgia: An effective therapy. Eur. Rev. Med. Pharmacol. Sci. 2019;23:1786\u20131788. doi: 10.26355/eurrev_201902_17141.", "ArticleIdList": ["10.26355/eurrev_201902_17141", "30840304"]}, {"Citation": "Moreno-Fern\u00e1ndez A., Mac\u00edas-Garc\u00eda L., Valverde-Moreno R., Ortiz T., Fern\u00e1ndez-Rodr\u00edguez A., Molin\u00ed-Estrada A., De-Miguel M. Autohemotherapy with ozone as a possible effective treatment for Fibromyalgia. Acta Reumatol. Port. 2019;44:244\u2013249. (In English)", "ArticleIdList": ["31575841"]}, {"Citation": "Zhang J.F., Williams J.P., Zhao Q.N., Liu H., An J.X. Combined high-voltage pulsed radiofrequency and ozone therapy versus ozone therapy alone in treating postherpetic neuralgia: A retrospective comparison. Med. Gas Res. 2023;13:15\u201322. doi: 10.4103/2045-9912.352660.", "ArticleIdList": ["10.4103/2045-9912.352660", "PMC9480353", "35946218"]}, {"Citation": "Hu B., Zheng J., Liu Q., Yang Y., Zhang Y. The effect and safety of ozone autohemotherapy combined with pharmacological therapy in postherpetic neuralgia. J. Pain Res. 2018;11:1637\u20131643. doi: 10.2147/JPR.S154154.", "ArticleIdList": ["10.2147/JPR.S154154", "PMC6118245", "30214273"]}, {"Citation": "Li L.-M., Zhang Z.-L., Zheng B.-S., Jia L.-L., Yu W.-L., Du H.-Y. Effective treatment of high-voltage pulsed radiofrequency combined with oxygen\u2013ozone injection in acute zoster neuralgia. Clin. Neurol. Neurosurg. 2022;223:107496. doi: 10.1016/j.clineuro.2022.107496.", "ArticleIdList": ["10.1016/j.clineuro.2022.107496", "36334554"]}, {"Citation": "Rowen R.J., Robins H. Ozone Therapy for Complex Regional Pain Syndrome: Review and Case Report. Curr. Pain Headache Rep. 2019;23:41. doi: 10.1007/s11916-019-0776-y.", "ArticleIdList": ["10.1007/s11916-019-0776-y", "PMC6502773", "31062104"]}, {"Citation": "Gaspary J. Ozone Therapy and Pulsed Electromagnetic Fields Interplay in Controlling Tumor Growth, Symptom and Pain Management: A Case Report. Int. J. Med. Res. Health Sci. 2020;14:313\u2013317."}, {"Citation": "Clavo B., Navarro M., Federico M., Borrelli E., Jorge I.J., Ribeiro I., Rodr\u00edguez-Melcon J.I., Caram\u00e9s M.A., Santana-Rodr\u00edguez N., Rodr\u00edguez-Esparrag\u00f3n F. Long-Term Results with Adjuvant Ozone Therapy in the Management of Chronic Pelvic Pain Secondary to Cancer Treatment. Pain Med. 2021;22:2138\u20132141. doi: 10.1093/pm/pnaa459.", "ArticleIdList": ["10.1093/pm/pnaa459", "PMC8557383", "33738491"]}, {"Citation": "Clavo B., Navarro M., Federico M., Borrelli E., Jorge I.J., Ribeiro I., Rodr\u00edguez-Melcon J.I., Caram\u00e9s M.A., Santana-Rodr\u00edguez N., Rodr\u00edguez-Esparrag\u00f3n F. Ozone Therapy in Refractory Pelvic Pain Syndromes Secondary to Cancer Treatment: A New Approach Warranting Exploration. J. Palliat. Med. 2021;24:97\u2013102. doi: 10.1089/jpm.2019.0597.", "ArticleIdList": ["10.1089/jpm.2019.0597", "32379556"]}, {"Citation": "Clavo B., Rodr\u00edguez-Abreu D., Galv\u00e1n S., Federico M., Mart\u00ednez-S\u00e1nchez G., Ramallo-Fari\u00f1a Y., Antonelli C., Ben\u00edtez G., Rey-Baltar D., Jorge I.J., et al. Long-term improvement by ozone treatment in chronic pain secondary to chemotherapy-induced peripheral neuropathy: A preliminary report. Front. Physiol. 2022;13:935269. doi: 10.3389/fphys.2022.935269.", "ArticleIdList": ["10.3389/fphys.2022.935269", "PMC9468657", "36111149"]}, {"Citation": "Sweet F., Kao M.S., Lee S.C., Hagar W.L., Sweet W.E. Ozone selectively inhibits growth of human cancer cells. Science. 1980;209:931\u2013933. doi: 10.1126/science.7403859.", "ArticleIdList": ["10.1126/science.7403859", "7403859"]}, {"Citation": "Smith N.L., Wilson A.L., Gandhi J., Vatsia S., Khan S.A. Ozone therapy: An overview of pharmacodynamics, current research, and clinical utility. Med. Gas Res. 2017;7:212\u2013219. doi: 10.4103/2045-9912.215752.", "ArticleIdList": ["10.4103/2045-9912.215752", "PMC5674660", "29152215"]}, {"Citation": "Amjad M.T., Chidharla A., Kasi A. StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2022. Cancer Chemotherapy.", "ArticleIdList": ["33232037"]}, {"Citation": "Maih\u00f6fner C., Diel I., Tesch H., Quandel T., Baron R. Chemotherapy-induced peripheral neuropathy (CIPN): Current therapies and topical treatment option with high-concentration capsaicin. Support Care Cancer. 2021;29:4223\u20134238. doi: 10.1007/s00520-021-06042-x.", "ArticleIdList": ["10.1007/s00520-021-06042-x", "PMC8236465", "33624117"]}, {"Citation": "Was H., Borkowska A., Bagues A., Tu L., Liu J.Y.H., Lu Z., Rudd J.A., Nurgali K., Abalo R. Mechanisms of Chemotherapy-Induced Neurotoxicity. Front. Pharmacol. 2022;13:750507. doi: 10.3389/fphar.2022.750507.", "ArticleIdList": ["10.3389/fphar.2022.750507", "PMC8996259", "35418856"]}, {"Citation": "Eldridge S., Guo L., Hamre J., 3rd A Comparative Review of Chemotherapy-Induced Peripheral Neuropathy in In Vivo and In Vitro Models. Toxicol. Pathol. 2020;48:190\u2013201. doi: 10.1177/0192623319861937.", "ArticleIdList": ["10.1177/0192623319861937", "PMC6917839", "31331249"]}, {"Citation": "Starobova H., Vetter I. Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy. Front. Mol. Neurosci. 2017;10:174. doi: 10.3389/fnmol.2017.00174.", "ArticleIdList": ["10.3389/fnmol.2017.00174", "PMC5450696", "28620280"]}, {"Citation": "Shim H.S., Bae C., Wang J., Lee K.-H., Hankerd K.M., Kim H.K., Chung J.M., La J.-H. Peripheral and central oxidative stress in chemotherapy-induced neuropathic pain. Mol. Pain. 2019;15:1\u201311. doi: 10.1177/1744806919840098.", "ArticleIdList": ["10.1177/1744806919840098", "PMC6458664", "30857460"]}, {"Citation": "Boyette-Davis J.A., Hou S., Abdi S., Dougherty P.M. An updated understanding of the mechanisms involved in chemotherapy-induced neuropathy. Pain Manag. 2018;8:363\u2013375. doi: 10.2217/pmt-2018-0020.", "ArticleIdList": ["10.2217/pmt-2018-0020", "PMC6462837", "30212277"]}, {"Citation": "Lazic A., Popovi\u0107 J., Paunesku T., Woloschak G.E., Stevanovi\u0107 M. Insights into platinum-induced peripheral neuropathy-current perspective. Neural Regen. Res. 2020;15:1623\u20131630. doi: 10.4103/1673-5374.276321.", "ArticleIdList": ["10.4103/1673-5374.276321", "PMC7437596", "32209761"]}, {"Citation": "Breitzig M., Bhimineni C., Lockey R., Kolliputi N. 4-Hydroxy-2-nonenal: A critical target in oxidative stress? Am. J. Physiol. Cell Physiol. 2016;311:C537\u2013C543. doi: 10.1152/ajpcell.00101.2016.", "ArticleIdList": ["10.1152/ajpcell.00101.2016", "PMC5129750", "27385721"]}, {"Citation": "Kanat O., Ertas H., Caner B. Platinum-induced neurotoxicity: A review of possible mechanisms. World J. Clin. Oncol. 2017;8:329\u2013335. doi: 10.5306/wjco.v8.i4.329.", "ArticleIdList": ["10.5306/wjco.v8.i4.329", "PMC5554876", "28848699"]}, {"Citation": "Grisold W., Cavaletti G., Windebank A.J. Peripheral neuropathies from chemotherapeutics and targeted agents: Diagnosis, treatment, and prevention. Neuro Oncol. 2012;14((Suppl. 4)):iv45\u2013iv54. doi: 10.1093/neuonc/nos203.", "ArticleIdList": ["10.1093/neuonc/nos203", "PMC3480245", "23095830"]}, {"Citation": "Cavaletti G., Ceresa C., Nicolini G., Marmiroli P. Neuronal drug transporters in platinum drugs-induced peripheral neurotoxicity. Anticancer Res. 2014;34:483\u2013486.", "ArticleIdList": ["24403505"]}, {"Citation": "Ta L.E., Espeset L., Podratz J., Windebank A.J. Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding. Neurotoxicology. 2006;27:992\u20131002. doi: 10.1016/j.neuro.2006.04.010.", "ArticleIdList": ["10.1016/j.neuro.2006.04.010", "16797073"]}, {"Citation": "Dzagnidze A., Katsarava Z., Makhalova J., Liedert B., Yoon M.S., Kaube H., Limmroth V., Thomale J. Repair capacity for platinum-DNA adducts determines the severity of cisplatin-induced peripheral neuropathy. J. Neurosci. 2007;27:9451\u20139457. doi: 10.1523/JNEUROSCI.0523-07.2007.", "ArticleIdList": ["10.1523/JNEUROSCI.0523-07.2007", "PMC6673116", "17728458"]}, {"Citation": "Podratz J.L., Knight A.M., Ta L.E., Staff N.P., Gass J.M., Genelin K., Schlattau A., Lathroum L., Windebank A.J. Cisplatin induced mitochondrial DNA damage in dorsal root ganglion neurons. Neurobiol. Dis. 2011;41:661\u2013668. doi: 10.1016/j.nbd.2010.11.017.", "ArticleIdList": ["10.1016/j.nbd.2010.11.017", "PMC3031677", "21145397"]}, {"Citation": "Hakiminia B., Goudarzi A., Moghaddas A. Has vitamin E any shreds of evidence in cisplatin-induced toxicity. J. Biochem. Mol. Toxicol. 2019;33:e22349. doi: 10.1002/jbt.22349.", "ArticleIdList": ["10.1002/jbt.22349", "31115123"]}, {"Citation": "Brandolini L., D\u2019Angelo M., Antonosante A., Allegretti M., Cimini A. Chemokine Signaling in Chemotherapy-Induced Neuropathic Pain. Int. J. Mol. Sci. 2019;20:2904. doi: 10.3390/ijms20122904.", "ArticleIdList": ["10.3390/ijms20122904", "PMC6627296", "31197114"]}, {"Citation": "Triarico S., Romano A., Attin\u00e0 G., Capozza M.A., Maurizi P., Mastrangelo S., Ruggiero A. Vincristine-Induced Peripheral Neuropathy (VIPN) in Pediatric Tumors: Mechanisms, Risk Factors, Strategies of Prevention and Treatment. Int. J. Mol. Sci. 2021;22:4112. doi: 10.3390/ijms22084112.", "ArticleIdList": ["10.3390/ijms22084112", "PMC8073828", "33923421"]}, {"Citation": "Lee J.J., Swain S.M. Peripheral neuropathy induced by microtubule-stabilizing agents. J. Clin. Oncol. 2006;24:1633\u20131642. doi: 10.1200/JCO.2005.04.0543.", "ArticleIdList": ["10.1200/JCO.2005.04.0543", "16575015"]}, {"Citation": "Rowinsky E.K., Donehower R.C. Paclitaxel (taxol) N. Engl. J. Med. 1995;332:1004\u20131014. doi: 10.1056/NEJM199504133321507. Erratum in N. Engl. J. Med. 1995, 333, 75.", "ArticleIdList": ["10.1056/NEJM199504133321507", "7885406"]}, {"Citation": "Shemesh O.A., Spira M.E. Paclitaxel induces axonal microtubules polar reconfiguration and impaired organelle transport: Implications for the pathogenesis of paclitaxel-induced polyneuropathy. Acta Neuropathol. 2010;119:235\u2013248. doi: 10.1007/s00401-009-0586-0.", "ArticleIdList": ["10.1007/s00401-009-0586-0", "19727778"]}, {"Citation": "Poruchynsky M.S., Sackett D.L., Robey R.W., Ward Y., Annunziata C., Fojo T. Proteasome inhibitors increase tubulin polymerization and stabilization in tissue culture cells: A possible mechanism contributing to peripheral neuropathy and cellular toxicity following proteasome inhibition. Cell Cycle. 2008;7:940\u2013949. doi: 10.4161/cc.7.7.5625.", "ArticleIdList": ["10.4161/cc.7.7.5625", "PMC9416319", "18414063"]}, {"Citation": "Shin Y.K., Jang S.Y., Lee H.K., Jung J., Suh D.J., Seo S.Y., Park H.T. Pathological adaptive responses of Schwann cells to endoplasmic reticulum stress in bortezomib-induced peripheral neuropathy. Glia. 2010;58:1961\u20131976. doi: 10.1002/glia.21065.", "ArticleIdList": ["10.1002/glia.21065", "20830808"]}, {"Citation": "Casafont I., Berciano M.T., Lafarga M. Bortezomib induces the formation of nuclear poly(A) RNA granules enriched in Sam68 and PABPN1 in sensory ganglia neurons. Neurotox. Res. 2010;17:167\u2013178. doi: 10.1007/s12640-009-9086-1.", "ArticleIdList": ["10.1007/s12640-009-9086-1", "19609631"]}, {"Citation": "Keifer J.A., Guttridge D.C., Ashburner B.P., Baldwin A.S., Jr. Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity. J. Biol. Chem. 2001;276:22382\u201322387. doi: 10.1074/jbc.M100938200.", "ArticleIdList": ["10.1074/jbc.M100938200", "11297551"]}, {"Citation": "De Logu F., Trevisan G., Marone I.M., Coppi E., Padilha Dalenogare D., Titiz M., Marini M., Landini L., Souza Monteiro de Araujo D., Li Puma S., et al. Oxidative stress mediates thalidomide-induced pain by targeting peripheral TRPA1 and central TRPV4. BMC Biol. 2020;18:197. doi: 10.1186/s12915-020-00935-9.", "ArticleIdList": ["10.1186/s12915-020-00935-9", "PMC7737339", "33317522"]}, {"Citation": "Gupta R., Bhaskar A. Chemotherapy-induced peripheral neuropathic pain. BJA Educ. 2016;16:115\u2013119. doi: 10.1093/bjaed/mkv044.", "ArticleIdList": ["10.1093/bjaed/mkv044"]}, {"Citation": "Yin Z.S., Zhang H., Bo W., Gao W. Erythropoietin promotes functional recovery and enhances nerve regeneration after peripheral nerve injury in rats. Am. J. Neuroradiol. 2010;31:509\u2013515. doi: 10.3174/ajnr.A1820.", "ArticleIdList": ["10.3174/ajnr.A1820", "PMC7963987", "20037135"]}, {"Citation": "Cervellini I., Bello E., Frapolli R., Porretta-Serapiglia C., Oggioni N., Canta A., Lombardi R., Camozzi F., Roglio I., Melcangi R.C., et al. The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats. Neurotox. Res. 2010;18:151\u2013160. doi: 10.1007/s12640-009-9127-9.", "ArticleIdList": ["10.1007/s12640-009-9127-9", "19876698"]}, {"Citation": "Kassem L.A., Yassin N.A. Role of erythropoeitin in prevention of chemotherapy-induced peripheral neuropathy. Pak. J. Biol. Sci. 2010;13:577\u2013587. doi: 10.3923/pjbs.2010.577.587.", "ArticleIdList": ["10.3923/pjbs.2010.577.587", "21061908"]}, {"Citation": "Bianchi R., Brines M., Lauria G., Savino C., Gilardini A., Nicolini G., Rodriguez-Menendez V., Oggioni N., Canta A., Penza P., et al. Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity. Clin. Cancer Res. 2006;12:2607\u20132612. doi: 10.1158/1078-0432.CCR-05-2177.", "ArticleIdList": ["10.1158/1078-0432.CCR-05-2177", "16638873"]}, {"Citation": "Bianchi R., Gilardini A., Rodriguez-Menendez V., Oggioni N., Canta A., Colombo T., De Michele G., Martone S., Sfacteria A., Piedemonte G., et al. Cisplatin-induced peripheral neuropathy: Neuroprotection by erythropoietin without affecting tumour growth. Eur. J. Cancer. 2007;43:710\u2013717. doi: 10.1016/j.ejca.2006.09.028.", "ArticleIdList": ["10.1016/j.ejca.2006.09.028", "17251006"]}, {"Citation": "Pradeep S., Huang J., Mora E.M., Nick A.M., Cho M.S., Wu S.Y., Noh K., Pecot C.V., Rupaimoole R., Stein M.A., et al. Erythropoietin Stimulates Tumor Growth via EphB4. Cancer Cell. 2015;28:610\u2013622. doi: 10.1016/j.ccell.2015.09.008.", "ArticleIdList": ["10.1016/j.ccell.2015.09.008", "PMC4643364", "26481148"]}, {"Citation": "Van den Heuvel S.A.S., van der Wal S.E.I., Smedes L.A., Radema S.A., van Alfen N., Vissers K.C.P., Steegers M.A.H. Intravenous Lidocaine: Old-School Drug, New Purpose-Reduction of Intractable Pain in Patients with Chemotherapy Induced Peripheral Neuropathy. Pain Res. Manag. 2017;2017:8053474. doi: 10.1155/2017/8053474.", "ArticleIdList": ["10.1155/2017/8053474", "PMC5387833", "28458593"]}, {"Citation": "Wiffen P.J., Derry S., Bell R.F., Rice A.S., T\u00f6lle T.R., Phillips T., Moore R.A. Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst. Rev. 2017;6:CD007938. doi: 10.1002/14651858.CD007938.pub4.", "ArticleIdList": ["10.1002/14651858.CD007938.pub4", "PMC6452908", "28597471"]}, {"Citation": "Cummins T.R. Setting up for the block: The mechanism underlying lidocaine\u2019s use-dependent inhibition of sodium channels. J. Physiol. 2007;582:11. doi: 10.1113/jphysiol.2007.136671.", "ArticleIdList": ["10.1113/jphysiol.2007.136671", "PMC2075285", "17525109"]}, {"Citation": "Kamei J., Nozaki C., Saitoh A. Effect of mexiletine on vincristine-induced painful neuropathy in mice. Eur. J. Pharmacol. 2006;536:123\u2013127. doi: 10.1016/j.ejphar.2006.02.033.", "ArticleIdList": ["10.1016/j.ejphar.2006.02.033", "16556439"]}, {"Citation": "Tremont-Lukats I.W., Challapalli V., McNicol E.D., Lau J., Carr D.B. Systemic Administration of Local Anesthetics to Relieve Neuropathic Pain: A Systematic Review and Meta-Analysis. Anesth. Analg. 2005;101:1738\u20131749. doi: 10.1213/01.ANE.0000186348.86792.38.", "ArticleIdList": ["10.1213/01.ANE.0000186348.86792.38", "16301253"]}, {"Citation": "Farshchian N., Alavi A., Heydarheydari S., Moradian N. Comparative study of the effects of venlafaxine and duloxetine on chemotherapy-induced peripheral neuropathy. Cancer Chemother. Pharmacol. 2018;82:787\u2013793. doi: 10.1007/s00280-018-3664-y.", "ArticleIdList": ["10.1007/s00280-018-3664-y", "30105459"]}, {"Citation": "Kaley T.J., Deangelis L.M. Therapy of chemotherapy-induced peripheral neuropathy. Br. J. Haematol. 2009;145:3\u201314. doi: 10.1111/j.1365-2141.2008.07558.x.", "ArticleIdList": ["10.1111/j.1365-2141.2008.07558.x", "19170681"]}, {"Citation": "Markman J.D., Jensen T.S., Semel D., Li C., Parsons B., Behar R., Sadosky A.B. Effects of Pregabalin in Patients with Neuropathic Pain Previously Treated with Gabapentin: A Pooled Analysis of Parallel-Group, Randomized, Placebo-controlled Clinical Trials. Pain Pract. 2017;17:718\u2013728. doi: 10.1111/papr.12516.", "ArticleIdList": ["10.1111/papr.12516", "27611736"]}, {"Citation": "Micov A.M., Tomi\u0107 M.A., Todorovi\u0107 M.B., Vukovi\u0107 M.J., Pecikoza U.B., Jasnic N.I., Djordjevic J.D., Stepanovi\u0107-Petrovi\u0107 R.M. Vortioxetine reduces pain hypersensitivity and associated depression-like behavior in mice with oxaliplatin-induced neuropathy. Prog. Neuro Psychopharmacol. Biol. Psychiatry. 2020;103:109975. doi: 10.1016/j.pnpbp.2020.109975.", "ArticleIdList": ["10.1016/j.pnpbp.2020.109975", "32464241"]}, {"Citation": "Majsterek I., Gloc E., Blasiak J., Reiter R.J. A comparison of the action of amifostine and melatonin on DNA-damaging effects and apoptosis induced by idarubicin in normal and cancer cells. J. Pineal Res. 2005;38:254\u2013263. doi: 10.1111/j.1600-079X.2005.00197.x.", "ArticleIdList": ["10.1111/j.1600-079X.2005.00197.x", "15813902"]}, {"Citation": "Hilpert F., St\u00e4hle A., Tom\u00e9 O., Burges A., Rossner D., Sp\u00e4the K., Heilmann V., Richter B., du Bois A. Arbeitsgemeinschaft Gyn\u00e4kologische Onkologoie (AGO) Ovarian Cancer Study Group. Neuroprotection with amifostine in the first-line treatment of advanced ovarian cancer with carboplatin/paclitaxel-based chemotherapy--A double-blind, placebo-controlled, randomized phase II study from the Arbeitsgemeinschaft Gyn\u00e4kologische Onkologoie (AGO) Ovarian Cancer Study Group. Support Care Cancer. 2005;13:797\u2013805. doi: 10.1007/s00520-005-0782-y.", "ArticleIdList": ["10.1007/s00520-005-0782-y", "16025262"]}, {"Citation": "Karlsson J.O.G., Andersson R.G., Jynge P. Mangafodipir a Selective Cytoprotectant\u2014With Special Reference to Oxaliplatin and Its Association to Chemotherapy-Induced Peripheral Neuropathy (CIPN) Transl. Oncol. 2017;10:641\u2013649. doi: 10.1016/j.tranon.2017.04.012.", "ArticleIdList": ["10.1016/j.tranon.2017.04.012", "PMC5496205", "28668762"]}, {"Citation": "Baeza J., Cabo J.R., G\u00f3mez M., Men\u00e9ndez S., Re L. WFOTs Review on Evidence Based Ozone Therapy. Volume 116 World Federation of Ozone Therapy; Brescia, Italy: 2015."}, {"Citation": "Ajamieh H.H., Men\u00e9ndez S., Merino N., Mart\u00ednez-S\u00e1nchez G., Re L., Le\u00f3n O.S. Ischemic and Ozone Oxidative Preconditioning in the Protection Against Hepatic Ischemic-Reperfusion Injury. Ozone Sci. Eng. 2003;25:241\u2013250. doi: 10.1080/01919510390481568.", "ArticleIdList": ["10.1080/01919510390481568"]}, {"Citation": "Ajamieh H.H., Men\u00e9ndez S., Mart\u00ednez-S\u00e1nchez G., Candelario-Jalil E., Re L., Giuliani A., Fern\u00e1ndez O.S. Effects of ozone oxidative preconditioning on nitric oxide generation and cellular redox balance in a rat model of hepatic ischaemia-reperfusion. Liver Int. 2004;24:55\u201362. doi: 10.1111/j.1478-3231.2004.00885.x.", "ArticleIdList": ["10.1111/j.1478-3231.2004.00885.x", "15102001"]}, {"Citation": "Ajamieh H.H., Berlanga J., Merino N., S\u00e1nchez G.M., Carmona A.M., Cepero S.M., Giuliani A., Re L., Le\u00f3n O.S. Role of protein synthesis in the protection conferred by ozone-oxidative-preconditioning in hepatic ischaemia/reperfusion. Transpl. Int. 2005;18:604\u2013612. doi: 10.1111/j.1432-2277.2005.00101.x.", "ArticleIdList": ["10.1111/j.1432-2277.2005.00101.x", "15819811"]}, {"Citation": "Peralta C., Xaus C., Bartrons R., Leon O.S., Gelpi E., Rosell\u00f3-Catafau J. Effect of ozone treatment on reactive oxygen species and adenosine production during hepatic ischemia-reperfusion. Free Radic. Res. 2000;33:595\u2013605. doi: 10.1080/10715760000301121.", "ArticleIdList": ["10.1080/10715760000301121", "11200091"]}, {"Citation": "\u00d6ks\u00fcz M., Y\u00fcce S., Ko\u00e7ak F., Canbaz Y., Ra\u011fbetli M., Mercantepe T. Effects of ozone pretreatment on viability of random pattern skin flaps in rats. J. Plast. Surg. Hand Surg. 2015;49:300\u2013305. doi: 10.3109/2000656X.2015.1047452.", "ArticleIdList": ["10.3109/2000656X.2015.1047452", "25998721"]}, {"Citation": "Fern\u00e1ndez-Cuadros M.E., P\u00e9rez-Moro O., Albaladejo-Flor\u00edn M.J., \u00c1lava-Rabasa S. El ozono intrarticular modula la inflamaci\u00f3n, mejora el dolor, la rigidez, la funci\u00f3n y tiene un efecto anab\u00f3lico sobre la artrosis de rodilla: Estudio cuasiexperimental prospectivo tipo antes-despu\u00e9s, 115 pacientes. Rev. De La Soc. Espa\u00f1ola Del Dolor. 2020;27:78\u201388."}, {"Citation": "Greene A.K., Few B.K., Serafini J.C. A comparison of ozonation and chlorination for the disinfection of stainless steel surfaces. J. Dairy Sci. 1993;76:3617\u20133620. doi: 10.3168/jds.S0022-0302(93)77702-4.", "ArticleIdList": ["10.3168/jds.S0022-0302(93)77702-4", "8270705"]}, {"Citation": "Re L., Sanchez G.M., Mawsouf N. Clinical evidence of ozone interaction with pain mediators. Saudi Med. J. 2010;31:1363\u20131367.", "ArticleIdList": ["21136002"]}, {"Citation": "Fuccio C., Luongo C., Capodanno P., Giordano C., Scafuro M.A., Siniscalco D., Lettieri B., Rossi F., Maione S., Berrino L. A single subcutaneous injection of ozone prevents allodynia and decreases the over-expression of pro-inflammatory caspases in the orbito-frontal cortex of neuropathic mice. Eur. J. Pharmacol. 2009;603:42\u201349. doi: 10.1016/j.ejphar.2008.11.060.", "ArticleIdList": ["10.1016/j.ejphar.2008.11.060", "19100257"]}, {"Citation": "Zhang W., Wang F., Zhang L., Sun T., Fu Z. Intrathecal injection of ozone alleviates CCI-induced neuropathic pain via the GluR6-NF-\u03baB/p65 signalling pathway in rats. Mol. Med. Rep. 2021;23:231. doi: 10.3892/mmr.2021.11870.", "ArticleIdList": ["10.3892/mmr.2021.11870", "33537798"]}, {"Citation": "Lu L., Pan C., Chen L., Hu L., Wang C., Han Y., Yang Y., Cheng Z., Liu W.-T. AMPK activation by peri-sciatic nerve administration of ozone attenuates CCI-induced neuropathic pain in rats. J. Mol. Cell Biol. 2017;9:132\u2013143. doi: 10.1093/jmcb/mjw043.", "ArticleIdList": ["10.1093/jmcb/mjw043", "27744376"]}, {"Citation": "Xu J., Wei X., Gao F., Zhong X., Guo R., Ji Y., Zhou X., Chen J., Yao P., Liu X., et al. Nicotinamide adenine dinucleotide phosphate oxidase 2\u2013derived reactive oxygen species contribute to long-term potentiation of C-fiber-evoked field potentials in spinal dorsal horn and persistent mirror-image pain following high-frequency stimulus of the sciatic nerve. Pain. 2020;161:758\u2013772. doi: 10.1097/j.pain.0000000000001761.", "ArticleIdList": ["10.1097/j.pain.0000000000001761", "32195784"]}, {"Citation": "Yowtak J., Lee K.Y., Kim H.Y., Wang J., Chung K., Chung J.M. Reactive oxygen species contribute to neuropathic pain by reducing spinal GABA release. Pain. 2011;152:844\u2013852. doi: 10.1016/j.pain.2010.12.034.", "ArticleIdList": ["10.1016/j.pain.2010.12.034", "PMC3108328", "21296500"]}, {"Citation": "Siemsen C.H. Ozon-Anwendung bei akuten und chronischen Gelenkerkrankungen. Ozon-Handbuch. Grundlagen. Pr\u00e4vention. Therapie. 1995:V-9.2.1\u2013V-9.2.14."}, {"Citation": "Iliakis E., Valadakis V., Vynios D., Tsiganos C., Agapitos E. Rationalization of the activity of medical ozone on intervertebral disc a histological and biochemical study. Riv. Di Neuroradiol. 2001;14:23\u201330. doi: 10.1177/19714009010140S105.", "ArticleIdList": ["10.1177/19714009010140S105"]}, {"Citation": "Leonardi M., Simonetti L., Barbara C. Effetti dell\u2019ozono sul nucleo polposo: Reperti anatomo-patologici su un caso operato. Riv. Di Neuroradiol. 2001;14:57\u201359. doi: 10.1177/19714009010140S113.", "ArticleIdList": ["10.1177/19714009010140S113"]}, {"Citation": "Bocci V., Pogni R., Corradeschi F., Busi E., Cervelli C., Bocchi L., Basosi R. Oxygen-ozone in orthopaedics: EPR detection of hydroxyl free radicals in ozone-treated nucleus pulposus material. Riv. Neuroradiol. 2001;14:55\u201359. doi: 10.1177/197140090101400106.", "ArticleIdList": ["10.1177/197140090101400106"]}, {"Citation": "Albertini F. Ozone administration in the treatment of herniated cervical disc. Case report. Riv. Ital. Ossigeno Ozonoterapia. 2002;1:203\u2013206."}, {"Citation": "Villa G. C6-C7 herniated disc treatment with paravertebral oxygen-ozone infiltration. Riv. Ital. Ossigeno Ozonoterapia. 2002;1:199\u2013201."}, {"Citation": "Moretti B., Lanzisera R., Pesce V., Moretti L., Patella S., Patella V.S.C. O2-O3 vs. anti-inflammatory drugs in the treatment of neck pain. Riv. Ital. Ossigeno Ozonoterapia. 2004;3:131\u2013137."}, {"Citation": "Xiao Y.Y., Tian J.L., Li J.K., Zhang J.S.C.T. Guided ozone injection for the treatment of cervical disc herniation. Riv. Ital. Ossigeno Ozonoterapia. 2006;5:109\u2013115."}, {"Citation": "Alexandre A., Cor\u00f2 L., Azuelos A., Buric J., Salgado H., Murga M., Marin F., Giocoli H. Advanced Peripheral Nerve Surgery and Minimal Invasive Spinal Surgery. Springer; Vienna, Austria: 2005. Intradiscal injection of oxygen-ozone gas mixture for the treatment of cervical disc herniations; pp. 79\u201382.", "ArticleIdList": ["15830973"]}, {"Citation": "Andreula C.F., Simonetti L., De Santis F., Agati R., Ricci R., Leonardi M. Minimally invasive oxygen-ozone therapy for lumbar disk herniation. Am. J. Neuroradiol. 2003;24:996\u20131000.", "ArticleIdList": ["PMC7975773", "12748111"]}, {"Citation": "Buric J., Alexandre A., Coro L., Azuelos A. Intradiscal ozone treatment of non-contained disc Herniations. Riv. Ital. Ossigeno-Ozone Ther. 2003;2:153\u2013160."}, {"Citation": "Magalhaes F.N., Dotta L., Sasse A., Teixera M.J., Fonoff E.T. Ozone therapy as a treatment for low back pain secondary to herniated disc: A systematic review and meta-analysis of randomized controlled trials. Pain Physician. 2012;15:E115\u2013E129.", "ArticleIdList": ["22430658"]}, {"Citation": "Muto M., Giurazza F., Silva R.P., Guarnieri G. Rational approach, technique and selection criteria treating lumbar disk herniations by oxygen-ozone therapy. Interv. Neuroradiol. 2016;22:736\u2013740. doi: 10.1177/1591019916659266.", "ArticleIdList": ["10.1177/1591019916659266", "PMC5564357", "27485047"]}, {"Citation": "Paoloni M., Di Sante L., Cacchio A., Apuzzo D., Marotta S., Razzano M., Franzini M., Santilli V. Intramuscular oxygen-ozone therapy in the treatment of acute back pain with lumbar disc herniation: A multicenter, randomized, double-blind, clinical trial of active and simulated lumbar paravertebral injection. Spine. 2009;34:1337\u20131344. doi: 10.1097/BRS.0b013e3181a3c18d.", "ArticleIdList": ["10.1097/BRS.0b013e3181a3c18d", "19478653"]}, {"Citation": "Steppan J., Meaders T., Muto M., Murphy K.J. A metaanalysis of the effectiveness and safety of ozone treatments for herniated lumbar discs. J. Vasc. Interv. Radiol. 2010;21:534\u2013548. doi: 10.1016/j.jvir.2009.12.393.", "ArticleIdList": ["10.1016/j.jvir.2009.12.393", "20188591"]}, {"Citation": "Torres L., Terrero M., Vidal M., Arag\u00f3n F., Mart\u00ednez J. Disc\u00f3lisis con ozono intradiscal en el tratamiento de la ci\u00e1tica por hernia discal. Seguimiento de 100 pacientes en 24 meses. Rev. Soc. Espa\u00f1ola Dolor. 2009;16:147\u2013152. doi: 10.1016/S1134-8046(09)71006-7.", "ArticleIdList": ["10.1016/S1134-8046(09)71006-7"]}, {"Citation": "Zambello A., Fara B., Tabaracci G., Bianchi M. Epidural steroid injection vs paravertebral O2-O3 infiltration for symptomatic herniated disc refractory to conventional treatment: A prospective randomized study. Riv. Ital. Ossigeno Ozonoterapia. 2006;5:123\u2013127."}, {"Citation": "Calunga Fern\u00e1ndez J.L., Ramos Parra T.L., Castillo P., Men\u00e9ndez S., Carballo A., C\u00e9spedes J. Ozonoterapia combinada en el tratamiento del paciente portador de hernia discal lumbar: Estudio preliminar. Rev. Cuba. Investig. Biom\u00e9dicas. 2007;26:1."}, {"Citation": "Bonetti M., Fontana A., Cotticelli B., Volta G.D., Guindani M., Leonardi M. Intraforaminal O(2)-O(3) versus periradicular steroidal infiltrations in lower back pain: Randomized controlled study. Am. J. Neuroradiol. 2005;26:996\u20131000.", "ArticleIdList": ["PMC8158626", "15891150"]}, {"Citation": "Muto M., Ambrosanio G., Guarnieri G., Capobianco E., Piccolo G., Annunziata G., Rotondo A. Low back pain and sciatica: Treatment with intradiscal-intraforaminal O(2)-O(3) injection. Our experience. Radiol. Med. 2008;113:695\u2013706. doi: 10.1007/s11547-008-0302-5.", "ArticleIdList": ["10.1007/s11547-008-0302-5", "18594765"]}, {"Citation": "Biazzo A., Corriero A.S., Confalonieri N. Intramuscular oxygen-ozone therapy in the treatment of low back pain. Acta Biomed. 2018;89:41\u201346. doi: 10.23750/abm.v89i1.5315.", "ArticleIdList": ["10.23750/abm.v89i1.5315", "PMC6357609", "29633741"]}, {"Citation": "Andr\u00e9s-Cano P., Vela T., Cano C., Garc\u00eda G., Vera J.C., Andr\u00e9s-Garc\u00eda J.A. Cervical Spondylodiscitis After Oxygen-Ozone Therapy for Treatment of a Cervical Disc Herniation: A Case Report and Review of the Literature. HSS J. 2016;12:278\u2013283. doi: 10.1007/s11420-016-9500-1.", "ArticleIdList": ["10.1007/s11420-016-9500-1", "PMC5026656", "27703423"]}, {"Citation": "Moretti B., Lanzisera R., Morese A., Moretti L., Patella S., Patella V., Simone C. O2-O3 vs chondroprotectors in the treatment of osteoarthritis of the knee. Riv. Ital. Ossigeno Ozonoterapia. 2004;3:65\u201372."}, {"Citation": "Riva Sanseverino E. Knee-joint disorders treated by oxygen-ozone therapy. Eur. Med. 1989;25:163\u2013170."}, {"Citation": "De Jesus C.C.L., Dos Santos F.C., De Jesus L.M.O.B., Monteiro I., Sant\u2019Ana M.S.S.C., Trevisani V. Comparison between intra-articular ozone and placebo in the treatment of knee osteoarthritis: A randomized, double-blinded, placebo-controlled study. PLoS ONE. 2017;12:e0179185. doi: 10.1371/journal.pone.0179185.", "ArticleIdList": ["10.1371/journal.pone.0179185", "PMC5524330", "28738079"]}, {"Citation": "Gheza G., Bissolotti L. Intra-articular oxygen-ozone injection for knee disease. Proposed guidelines. Riv. Ital. Ossigeno Ozonoterapia. 2003;2:63\u201366."}, {"Citation": "Giombini A., Menotti F., Di Cesare A., Giovannangeli F., Rizzo M., Moffa S., Martinelli F. Comparison between intrarticular injection of hyaluronic acid, oxygen ozone, and the combination of both in the treatment of knee osteoarthrosis. J. Biol. Regul. Homeost. Agents. 2016;30:621\u2013625.", "ArticleIdList": ["27358159"]}, {"Citation": "Li Q., Qi X., Zhang Z. Intra-articular oxygen-ozone versus hyaluronic acid in knee osteoarthritis: A meta-analysis of randomized controlled trials. Int. J. Surg. 2018;58:3\u201310. doi: 10.1016/j.ijsu.2018.08.007.", "ArticleIdList": ["10.1016/j.ijsu.2018.08.007", "30170178"]}, {"Citation": "Sconza C., Respizzi S., Virelli L., Vandenbulcke F., Iacono F., Kon E., Di Matteo B. Oxygen-Ozone Therapy for the Treatment of Knee Osteoarthritis: A Systematic Review of Randomized Controlled Trials. Arthroscopy. 2020;36:277\u2013286. doi: 10.1016/j.arthro.2019.05.043.", "ArticleIdList": ["10.1016/j.arthro.2019.05.043", "31679646"]}, {"Citation": "Noori-Zadeh A., Bakhtiyari S., Khooz R., Haghani K., Darabi S. Intra-articular ozone therapy efficiently attenuates pain in knee osteoarthritic subjects: A systematic review and meta-analysis. Complement. Ther. Med. 2019;42:240\u2013247. doi: 10.1016/j.ctim.2018.11.023.", "ArticleIdList": ["10.1016/j.ctim.2018.11.023", "30670248"]}, {"Citation": "Arias-V\u00e1zquez P.I., Tovilla-Z\u00e1rate C.A., Bermudez-Oca\u00f1a D.Y., Legorreta-Ram\u00edrez B.G., L\u00f3pez-Narv\u00e1ez M.L. Eficacia de las infiltraciones con ozono en el tratamiento de la osteoartritis de rodilla vs. otros tratamientos intervencionistas: Revisi\u00f3n sistem\u00e1tica de ensayos cl\u00ednicos [Efficacy of Ozone Infiltrations in the Treatment of Knee Osteoarthritis Vs Other Interventional Treatments: A Systematic Review of Clinical Trials] Rehabilitacion. 2019;53:43\u201355. doi: 10.1016/j.rh.2018.11.001. (In Spanish)", "ArticleIdList": ["10.1016/j.rh.2018.11.001", "30929831"]}, {"Citation": "Raeissadat S.A., Tabibian E., Rayegani S.M., Rahimi-Dehgolan S., Babaei-Ghazani A. An investigation into the efficacy of intra-articular ozone (O2-O3) injection in patients with knee osteoarthritis: A systematic review and meta-analysis. J. Pain Res. 2018;11:2537\u20132550. doi: 10.2147/JPR.S175441.", "ArticleIdList": ["10.2147/JPR.S175441", "PMC6207244", "30498370"]}, {"Citation": "Costa T., Rodrigues-Manica S., Lopes C., Gomes J., Marona J., Falc\u00e3o S., Branco J. Ozonoterapia na Osteoartrose do Joelho: Revis\u00e3o Sistem\u00e1tica [Ozone Therapy in Knee Osteoarthritis: A Systematic Review] Acta Med. Port. 2018;31:576\u2013580. doi: 10.20344/amp.10330. (In Portuguese)", "ArticleIdList": ["10.20344/amp.10330", "30387426"]}, {"Citation": "Paolucci T., Agostini F., Bernetti A., Paoloni M., Mangone M., Santilli V., Pezzi L., Bellomo R.G., Saggini R. Integration of focal vibration and intra-articular oxygen-ozone therapy in rehabilitation of painful knee osteoarthritis. J. Int. Med. Res. 2021;49:300060520986705. doi: 10.1177/0300060520986705.", "ArticleIdList": ["10.1177/0300060520986705", "PMC7923992", "33641438"]}, {"Citation": "Gjonovich A., Marchetto R., Montemar\u00e0 E., Girotto T. Refractory tendinopathies of the knee: Use of oxygen-ozone therapy. Riv. Ital. Ossigeno Ozonoterapia. 2003;2:187\u2013192."}, {"Citation": "Hidalgo F.J., Calandre E., Rico F., Delgado A., Entrena J.M., Men\u00e9ndez S. Interest of systemic ozone in the treatment of highly refractory fibromyalgia; Proceedings of the IV Jornadas Nacionales de Ox\u00edgeno-ozonoterapia M\u00e9dica; Sevilla, Spain. 4\u20135 November 2005."}, {"Citation": "Clavo B., Santana-Rodriguez N., Gutierrez D., Lopez J.C., Suarez G., Lopez L., Robaina F., Bocci V. Long-term improvement in refractory headache following ozone therapy. J. Altern. Complement. Med. 2013;19:453\u2013458. doi: 10.1089/acm.2012.0273.", "ArticleIdList": ["10.1089/acm.2012.0273", "23215625"]}, {"Citation": "Ozbay I., Ital I., Kucur C., Akc\u0131lar R., Deger A., Aktas S., Oghan F. Effects of ozone therapy on facial nerve regeneration. Braz. J. Otorhinolaryngol. 2017;83:168\u2013175. doi: 10.1016/j.bjorl.2016.02.009.", "ArticleIdList": ["10.1016/j.bjorl.2016.02.009", "PMC9442687", "27174776"]}, {"Citation": "Somay H., Emon S.T., Uslu S., Orakdogen M., Meric Z.C., Ince U., Hakan T. The Histological Effects of Ozone Therapy on Sciatic Nerve Crush Injury in Rats. World Neurosurg. 2017;105:702\u2013708. doi: 10.1016/j.wneu.2017.05.161.", "ArticleIdList": ["10.1016/j.wneu.2017.05.161", "28587982"]}, {"Citation": "Effectiveness and Cost-Effectiveness of Ozone Therapy in Patients with Pain Secondary to Chemotherapy-Induced Peripheral Neuropathy. Randomized, Triple-Blind Clinical Trial (O3NPIQ). ClinicalTrials.gov Identifier: NCT04299893. Updated 15 November 2022.  [(accessed on 25 December 2022)]; Available online:  https://www.clinicaltrials.gov/ct2/show/NCT04299893."}, {"Citation": "Prospective and Observational Study of Patients Referred to the Chronic Pain Unit for Palliative Treatment with Ozone Therapy between 2022 and 2025. (EPOOzo). ClinicalTrials.gov Identifier: NCT05417737. Updated 16 June 2022.  [(accessed on 25 December 2022)]; Available online:  https://www.clinicaltrials.gov/ct2/show/NCT05417737."}, {"Citation": "Intraarticular Ozone Therapy for Pain Control in Osteoarthritis of the Knee between 2009 and 2016 ClinicalTrials.gov Identifier: NCT00832312.  [(accessed on 25 December 2022)]; Available online:  https://beta.clinicaltrials.gov/study/NCT00832312."}, {"Citation": "Study on the Effects of Oxygen-Ozone Therapy on Back Pain in Subjects Aged 65 or Older between 2012 and 2015. ClinicalTrials.gov Identifier: NCT01709058.  [(accessed on 25 December 2022)]; Available online:  https://beta.clinicaltrials.gov/study/NCT01709058."}, {"Citation": "Clinical Effects of Ozone Therapy in Cervical Disc Hernia between 2017 and 2019. ClinicalTrials.gov Identifier: NCT03056911.  [(accessed on 25 December 2022)]; Available online:  https://beta.clinicaltrials.gov/study/NCT03056911."}, {"Citation": "Ozone Therapy for Masticatory Muscle Pain (OTMMP) between 2014 and 2017. ClinicalTrials.gov Identifier: NCT02997410.  [(accessed on 25 December 2022)]; Available online:  https://beta.clinicaltrials.gov/study/NCT02997410."}, {"Citation": "Ozone Therapy in Patients with Diabetic Neuropathy between 2022 and 2022. ClinicalTrials.gov Identifier: NCT05000463.  [(accessed on 25 December 2022)]; Available online:  https://beta.clinicaltrials.gov/study/NCT05000463."}, {"Citation": "The Effect of Ozone Therapy on Pain Perception After Free Gingival Graft Surgery in Patients with Mucogingival Defects between 2022 and 2023. ClinicalTrials.gov Identifier: NCT05291715.  [(accessed on 25 December 2022)]; Available online:  https://beta.clinicaltrials.gov/study/NCT05291715."}, {"Citation": "The Effect of Epiduroscopy and Ozone Therapy in Patients with Failed Back Surgery Syndrome between 2009 and 2012. ClinicalTrials.gov Identifier: NCT01172457.  [(accessed on 25 December 2022)]; Available online:  https://beta.clinicaltrials.gov/study/NCT01172457."}, {"Citation": "Evaluation of Response to Use of Intravesical Ozone Gas in Interstitial Cystitis /Bladder Pain Syndrome between 2020 and 2021. ClinicalTrials.gov Identifier: NCT04789135.  [(accessed on 25 December 2022)]; Available online:  https://beta.clinicaltrials.gov/study/NCT04789135."}, {"Citation": "Rania V., Marcian\u00f2 G., Casarella A., Vocca C., Palleria C., Calabria E., Spaziano G., Citraro R., De Sarro G., Monea F., et al. Oxygen-Ozone Therapy in Cervicobrachial Pain: A Real-Life Experience. J. Clin. Med. 2022;12:248. doi: 10.3390/jcm12010248.", "ArticleIdList": ["10.3390/jcm12010248", "PMC9820947", "36615046"]}, {"Citation": "Comparative Effect of Transforaminal Injection of Magnesium Sulphate Versus Ozone Therapy on Oxidative Stress Biomarkers in Lumbar Disc Related Radicular Pain between 2020 and 2021. ClinicalTrials.gov Identifier: NCT04562493.  [(accessed on 25 December 2022)]; Available online:  https://beta.clinicaltrials.gov/study/NCT04562493.", "ArticleIdList": ["PMC9358797", "35941548"]}, {"Citation": "Magalh\u00e3es F.N., Soares S.C., Torres J.M., Ungaretti A., Cacciacarro M.F., Teixeira M.J., Fonoff E.T. Effects of ozone applied by spinal endoscopy in patients with chronic pain related to failed back surgery syndrome: A pilot study. Neuropsychiatr. Dis. Treat. 2013;9:1759\u20131766. doi: 10.2147/NDT.S48663.", "ArticleIdList": ["10.2147/NDT.S48663", "PMC3833839", "24259984"]}, {"Citation": "Clavo B., Santana-Rodr\u00edguez N., Llontop P., Guti\u00e9rrez D., Su\u00e1rez G., L\u00f3pez L., Rovira G., Mart\u00ednez-S\u00e1nchez G., Gonz\u00e1lez E., Jorge I.J., et al. Ozone Therapy as Adjuvant for Cancer Treatment: Is Further Research Warranted? Evid.-Based Complement. Altern. Med. 2018;2018:7931849. doi: 10.1155/2018/7931849.", "ArticleIdList": ["10.1155/2018/7931849", "PMC6151231", "30271455"]}, {"Citation": "Perez R. The Use of Ozone Therapy as Adjuvant Therapy in Cancer: A Review of the Literature. University of Las Palmas de Gran Canaria; Las Palmas, Spain: 2018."}, {"Citation": "Vaupel P., H\u00f6ckel M., Mayer A. Detection and characterization of tumor hypoxia using pO2 histography. Antioxid. Redox Signal. 2007;9:1221\u20131235. doi: 10.1089/ars.2007.1628.", "ArticleIdList": ["10.1089/ars.2007.1628", "17536958"]}, {"Citation": "Bocci V., Larini A., Micheli V. Restoration of Normoxia by Ozone Therapy May Control Neoplastic Growth: A Review and a Working Hypothesis. J. Altern. Complement. Med. 2005;11:257\u2013265. doi: 10.1089/acm.2005.11.257.", "ArticleIdList": ["10.1089/acm.2005.11.257", "15865491"]}, {"Citation": "Luongo M., Brigida A.L., Mascolo L., Gaudino G. Possible Therapeutic Effects of Ozone Mixture on Hypoxia in Tumor Development. Anticancer. Res. Febr. 2017;37:425\u2013435. doi: 10.21873/anticanres.11334.", "ArticleIdList": ["10.21873/anticanres.11334", "28179287"]}, {"Citation": "Clavo B., Santana-Rodriguez N., Llontop P., Gutierrez D., Ceballos D., M\u00e9ndez C., Rovira G., Suarez G., Rey-Baltar D., Garcia-Cabrera L., et al. Ozone Therapy in the Management of Persistent Radiation-Induced Rectal Bleeding in Prostate Cancer Patients. Evid. Based Complement. Altern. Med. 2015;2015:480369. doi: 10.1155/2015/480369.", "ArticleIdList": ["10.1155/2015/480369", "PMC4556325", "26357522"]}, {"Citation": "Nordsmark M., Bentzen S.M., Rudat V., Brizel D., Lartigau E., Stadler P., Becker A., Adam M., Molls M., Dunst J., et al. Prognostic value of tumor oxygenation in 397 head and neck tumors afer primary radiation therapy. An international multi-center study. Radiother. Oncol. 2005;77:18\u201324. doi: 10.1016/j.radonc.2005.06.038.", "ArticleIdList": ["10.1016/j.radonc.2005.06.038", "16098619"]}, {"Citation": "Clavo B., Robaina F., Fiuza D., Ruiz A., Lloret M., Rey-Baltar D., Llontop P., Riveros A., Rivero J., Casta\u00f1eda F., et al. Predictive value of hypoxia in advanced head and neck cancer after treatment with hyperfractionated radio-chemotherapy and hypoxia modification. Clin. Transl. Oncol. 2017;19:419\u2013424. doi: 10.1007/s12094-016-1541-x.", "ArticleIdList": ["10.1007/s12094-016-1541-x", "27527617"]}, {"Citation": "Men\u00e9ndez S., Cepero J., Borrego L. Ozone Therapy in Cancer Treatment: State of the Art. Ozone: Sci. Eng. 2008;30:398\u2013404. doi: 10.1080/01919510802473724.", "ArticleIdList": ["10.1080/01919510802473724"]}, {"Citation": "Aslaner A., \u00c7ak\u0131r T., \u00c7elik B., Do\u011fan U., Mayir B., Aky\u00fcz C., Polat C., Ba\u015ft\u00fcrk A., Soyer V., Ko\u00e7 S., et al. Does intraperitoneal medical ozone preconditioning and treatment ameliorate the methotrexate induced nephrotoxicity in rats? Int. J. Clin. Exp. Med. 2015;8:13811\u201313817.", "ArticleIdList": ["PMC4613015", "26550330"]}, {"Citation": "Clavo B., P\u00e9rez J.L., L\u00f3pez L., Su\u00e1rez G., Lloret M., Rodr\u00edguez V., Mac\u00edas D., Santana M., Hern\u00e1ndez M.A., Mart\u00edn-Oliva R., et al. Ozone Therapy for Tumor Oxygenation: A Pilot Study. Evid. Based Complement. Altern. Med. 2004;1:437019. doi: 10.1093/ecam/neh009.", "ArticleIdList": ["10.1093/ecam/neh009", "PMC442111", "15257330"]}, {"Citation": "Delgado-Roche L., Hern\u00e1ndez-Matos Y., Medina E.A., Morej\u00f3n D.\u00c1., Gonz\u00e1lez M.R., Mart\u00ednez-S\u00e1nchez G. Ozone-Oxidative Preconditioning Prevents Doxorubicin-induced Cardiotoxicity in Sprague-Dawley Rats. Sultan Qaboos Univ. Med. J. 2014;14:e342\u2013e348.", "ArticleIdList": ["PMC4117659", "25097769"]}, {"Citation": "Kuroda K., Azuma K., Mori T., Kawamoto K., Murahata Y., Tsuka T., Osaki T., Ito N., Imagawa T., Itoh F., et al. The Safety and Anti-Tumor Effects of Ozonated Water In Vivo. Int. J. Mol. Sci. 2015;16:25108\u201325120. doi: 10.3390/ijms161025108.", "ArticleIdList": ["10.3390/ijms161025108", "PMC4632793", "26506343"]}, {"Citation": "Luongo M., Marinelli O., Zeppa L., Aguzzi C., Morelli M.B., Amantini C., Frassineti A., di Costanzo M., Fanelli A., Santoni G., et al. Cannabidiol and Oxygen-Ozone Combination Induce Cytotoxicity in Human Pancreatic Ductal Adenocarcinoma Cell Lines. Cancers. 2020;12:2774. doi: 10.3390/cancers12102774.", "ArticleIdList": ["10.3390/cancers12102774", "PMC7600087", "32992648"]}, {"Citation": "Avil\u00e9s M.H., Rojo A.M.M., Gonz\u00e1lez R.A. Ozone Therapy as a coadjuvant treatment in veterinary oncology. Case reports. Ozone Ther. Glob. J. 2016;6:231\u2013236."}, {"Citation": "Clavo B., Ceballos D., Gutierrez D., Rovira G., Suarez G., Lopez L., Pinar B., Cabezon A., Morales V., Oliva E., et al. Long-term control of refractory hemorrhagic radiation proctitis with ozone therapy. J. Pain Symptom Manag. 2013;46:106\u2013112. doi: 10.1016/j.jpainsymman.2012.06.017.", "ArticleIdList": ["10.1016/j.jpainsymman.2012.06.017", "23102757"]}, {"Citation": "Shenberg J.E., Blum C. Gaseous and aqueous ozone therapy for treatment of mucositis secondary to chemotherapy/radiotherapy: A case report. Pain Pract. 2011;21:69\u201373."}, {"Citation": "Oldoini G., Frabattista G.R., Saragoni M., Cosola S., Giammarinaro E., Genovesi A.M., Marconcini S. Ozone Therapy for Oral Palatal Ulcer in a Leukaemic Patient. Eur. J. Case Rep. Intern. Med. 2020;7:001406. doi: 10.12890/2020_001406.", "ArticleIdList": ["10.12890/2020_001406", "PMC7050963", "32133312"]}, {"Citation": "Yu Q., Zhang C., Yang X., Zhang X., Wang C., Yang Y., Chen L., Liu X., Gu Y., Hu L., et al.  AMPK Activation by Ozone Therapy Inhibits Tissue Factor-Triggered Intestinal Ischemia and Ameliorates Chemotherapeutic Enteritis.  [(accessed on 22 October 2019)].  Available online:  https://ssrn.com/abstract=3474493.", "ArticleIdList": ["32776374"]}, {"Citation": "Petrucci M.T., Gallucci C., Agrillo A., Mustazza M.C., Fo\u00e0 R. Role of ozone therapy in the treatment of osteonecrosis of the jaws in multiple myeloma patients. Haematologica. 2007;92:1289\u20131290. doi: 10.3324/haematol.11096.", "ArticleIdList": ["10.3324/haematol.11096", "17768133"]}, {"Citation": "Agrillo A., Ungari C., Filiaci F., Priore P., Iannetti G. Ozone Therapy in the Treatment of Avascular Bisphosphonate-Related Jaw Osteonecrosis. J. Craniofacial Surg. 2007;18:1071\u20131075. doi: 10.1097/scs.0b013e31857261f.", "ArticleIdList": ["10.1097/scs.0b013e31857261f", "17912085"]}, {"Citation": "Oliveira C.C.B., Dantas J.B.D.L., Borges D.D.P.O., Martins G.B., Medrado A.R.A.P., Reis J.V.N.A., Marchionni A.M.T. Ozonotherapy for Treatment of Radiation Therapy-induced Jaw Osteonecrosis and Bisphosphonates: Case Report. Rev. Bras. De Cancerol. 2021;67:02785."}, {"Citation": "Kachalina E., Kontorschikova E., Novikov V., Yanchenko O. The use of Ozonized Physiologic Saline in Gynecologic patients with Uterine Myoma and Endometrial Cancer in the Postsurgical Period. Ozone Ther. Glob. J. 2017;7:77\u201381."}, {"Citation": "Clavo B., Ruiz A., Lloret M., L\u00f3pez L., Su\u00e1rez G., Mac\u00edas D., Rodr\u00edguez V., Hern\u00e1ndez M.A., Mart\u00edn-Oliva R., Quintero S., et al. Adjuvant Ozonetherapy in Advanced Head and Neck Tumors: A Comparative Study. Evid. Based Complement. Altern. Med. 2004;1:581750. doi: 10.1093/ecam/neh038.", "ArticleIdList": ["10.1093/ecam/neh038", "PMC538509", "15841266"]}, {"Citation": "Tirelli U., Cirrito C., Pavanello M., Del Pup L., Lleshi A., Berretta M. Oxygen-ozone therapy as support and palliative therapy in 50 cancer patients with fatigue\u2014A short report. Eur. Rev Med. Pharmacol. Sci. 2018;22:8030\u20138033.", "ArticleIdList": ["30536352"]}, {"Citation": "Pergolizzi J.V., Gharibo C., Ho K.Y. Treatment Considerations for Cancer Pain: A Global Perspective. Pain Pract. 2015;15:778\u2013792. doi: 10.1111/papr.12253.", "ArticleIdList": ["10.1111/papr.12253", "25469726"]}, {"Citation": "Schmidt B.L. The neurobiology of cancer pain. Neuroscientist. 2014;20:546\u2013562. doi: 10.1177/1073858414525828.", "ArticleIdList": ["10.1177/1073858414525828", "PMC4161642", "24664352"]}, {"Citation": "K\u0131z\u0131ltan H.\u015e., Bayir A.G., Yucesan G., Eris A.H., \u0130din K., Karatoprak C., Aydin T., Akcakaya A., Mayadagli A. Medical ozone and radiotherapy in a peritoneal, Erlich-ascites, tumor-cell model. Altern. Ther. Health Med. 2015;21:24\u201329.", "ArticleIdList": ["25830277"]}, {"Citation": "Clavo B., Rodr\u00edguez-Esparrag\u00f3n F., Rodr\u00edguez-Abreu D., Mart\u00ednez-S\u00e1nchez G., Llontop P., Aguiar-Bujanda D., Fern\u00e1ndez-P\u00e9rez L., Santana-Rodr\u00edguez N. Modulation of Oxidative Stress by Ozone Therapy in the Prevention and Treatment of Chemotherapy-Induced Toxicity: Review and Prospects. Antioxidants. 2019;8:588. doi: 10.3390/antiox8120588.", "ArticleIdList": ["10.3390/antiox8120588", "PMC6943601", "31779159"]}, {"Citation": "Ganesh Yerra V., Negi G., Sharma S.S., Kumar A. Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-\u03baB pathways in diabetic neuropathy. Redox Biol. 2013;1:394\u2013397. doi: 10.1016/j.redox.2013.07.005.", "ArticleIdList": ["10.1016/j.redox.2013.07.005", "PMC3757712", "24024177"]}, {"Citation": "Ahmed A.S., Berg S., Alkass K., Druid H., Hart D.A., Svensson C.I., Kosek E. NF-\u03baB-Associated Pain-Related Neuropeptide Expression in Patients with Degenerative Disc Disease. Int. J. Mol. Sci. 2019;20:658. doi: 10.3390/ijms20030658.", "ArticleIdList": ["10.3390/ijms20030658", "PMC6386867", "30717434"]}, {"Citation": "Liu C., Zhang F., Liu H., Wei F. NF-kB mediated CX3CL1 activation in the dorsal root ganglion contributes to the maintenance of neuropathic pain induced in adult male Sprague Dawley rats1. Acta Cir. Bras. 2018;33:619\u2013628. doi: 10.1590/s0102-865020180070000007.", "ArticleIdList": ["10.1590/s0102-865020180070000007", "30110063"]}, {"Citation": "Huang L.N., Zou Y., Wu S.G., Zhang H.H., Mao Q.X., Li J.B., Tao Y.X. Fn14 Participates in Neuropathic Pain Through NF-\u03baB Pathway in Primary Sensory Neurons. Mol. Neurobiol. 2019;56:7085\u20137096. doi: 10.1007/s12035-019-1545-y.", "ArticleIdList": ["10.1007/s12035-019-1545-y", "PMC6728171", "30976982"]}, {"Citation": "Sagai M., Bocci V. Mechanisms of Action Involved in Ozone Therapy: Is healing induced via a mild oxidative stress? Med. Gas Res. 2011;1:29. doi: 10.1186/2045-9912-1-29.", "ArticleIdList": ["10.1186/2045-9912-1-29", "PMC3298518", "22185664"]}, {"Citation": "Scassellati C., Ciani M., Galoforo A.C., Zanardini R., Bonvicini C., Geroldi C. Molecular mechanisms in cognitive frailty: Potential therapeutic targets for oxygen-ozone treatment. Mech. Ageing Dev. 2020;186:111210. doi: 10.1016/j.mad.2020.111210. Erratum in Mech. Ageing Dev. 2022, 207, 111729.", "ArticleIdList": ["10.1016/j.mad.2020.111210", "31982474"]}, {"Citation": "Valdenassi L., Franzini M., Ricevuti G., Rinaldi L., Galoforo A.C., Tirelli U. Potential mechanisms by which the oxygen-ozone (O2-O3) therapy could contribute to the treatment against the coronavirus COVID-19. Eur. Rev. Med. Pharmacol. Sci. 2020;24:4059\u20134061. doi: 10.26355/eurrev_202004_20976.", "ArticleIdList": ["10.26355/eurrev_202004_20976", "32374009"]}, {"Citation": "Yu G., Liu X., Chen Z., Chen H., Wang L., Wang Z., Qiu T., Weng X. Ozone therapy could attenuate tubulointerstitial injury in adenine-induced CKD rats by mediating Nrf2 and NF-\u03baB. Iran. J. Basic Med. Sci. 2016;19:1136\u20131143.", "ArticleIdList": ["PMC5110663", "27872711"]}, {"Citation": "Siniscalco D., Trotta M.C., Brigida A.L., Maisto R., Luongo M., Ferraraccio F., D\u2019Amico M., Di Filippo C. Intraperitoneal Administration of Oxygen/Ozone to Rats Reduces the Pancreatic Damage Induced by Streptozotocin. Biology. 2018;7:10. doi: 10.3390/biology7010010.", "ArticleIdList": ["10.3390/biology7010010", "PMC5872036", "29324687"]}, {"Citation": "Re L., Mart\u00ednez-S\u00e1nchez G., Bordicchia M., Malcangi G., Pocognoli A., Morales-Segura M.A., Rothchild J., Rojas A. Is ozone pre-conditioning effect linked to Nrf2/EpRE activation pathway in vivo? A preliminary result. Eur. J. Pharmacol. 2014;742:158\u2013162. doi: 10.1016/j.ejphar.2014.08.029.", "ArticleIdList": ["10.1016/j.ejphar.2014.08.029", "25218903"]}, {"Citation": "Delgado-Roche L., Riera-Romo M., Mesta F., Hern\u00e1ndez-Matos Y., Barrios J.M., Mart\u00ednez-S\u00e1nchez G., Al-Dalaien S.M. Medical ozone promotes Nrf2 phosphorylation reducing oxidative stress and pro-inflammatory cytokines in multiple sclerosis patients. Eur. J. Pharmacol. 2017;811:148\u2013154. doi: 10.1016/j.ejphar.2017.06.017.", "ArticleIdList": ["10.1016/j.ejphar.2017.06.017", "28623000"]}, {"Citation": "Brionne T.C., Tesseur I., Masliah E., Wyss-Coray T. Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron. 2003;40:1133\u20131145. doi: 10.1016/S0896-6273(03)00766-9.", "ArticleIdList": ["10.1016/S0896-6273(03)00766-9", "14687548"]}, {"Citation": "Echeverry S., Shi X.Q., Haw A., Liu G., Zhang Z., Zhang J. Transforming Growth Factor-\u03b21 Impairs Neuropathic Pain through Pleiotropic Effects. Mol. Pain. 2009;5:16. doi: 10.1186/1744-8069-5-16.", "ArticleIdList": ["10.1186/1744-8069-5-16", "PMC2669449", "19327151"]}, {"Citation": "Fern\u00e1ndez-Cuadros M.E., P\u00e9rez-Moro O.S., Albaladejo-Flor\u00edn M.J., Tobar-Izquierdo M.M., Maga\u00f1a-S\u00e1nchez A., Jim\u00e9nez-Cuevas P., Rodr\u00edguez-de-C\u00eda J. Intra Articular Ozone Modulates Inflammation and Has Anabolic Effect on Knee Osteoarthritis: IL-6 and IGF-1 as Pro-Inflammatory and Anabolic Biomarkers. Processes. 2022;10:138. doi: 10.3390/pr10010138.", "ArticleIdList": ["10.3390/pr10010138"]}, {"Citation": "Erken H.A., Gen\u00e7 O., Erken G., Ayada C., G\u00fcndo\u011fdu G., Do\u011fan H. Ozone partially prevents diabetic neuropathy in rats. Exp. Clin. Endocrinol. Diabetes. 2015;123:101\u2013105. doi: 10.1055/s-0034-1389954.", "ArticleIdList": ["10.1055/s-0034-1389954", "25502578"]}, {"Citation": "Luo W.J., Yang F., Yang F., Sun W., Zheng W., Wang X.L., Wu F.F., Wang J.L., Wang J.S., Guan S.M., et al. Intervertebral Foramen Injection of Ozone Relieves Mechanical Allodynia and Enhances Analgesic Effect of Gabapentin in Animal Model of Neuropathic Pain. Pain Physician. 2017;20:E673\u2013E685.", "ArticleIdList": ["28727712"]}, {"Citation": "Ogut E., Yildirim F.B., Sarikcioglu L., Aydin M.A., Demir N. Neuroprotective Effects of Ozone Therapy After Sciatic Nerve Cut Injury. Kurume Med. J. 2020;65:137\u2013144. doi: 10.2739/kurumemedj.MS654002.", "ArticleIdList": ["10.2739/kurumemedj.MS654002", "31391380"]}, {"Citation": "Flatters S., Dougherty P., Colvin L. Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): A narrative review. Br. J. Anaesth. 2017;119:737\u2013749. doi: 10.1093/bja/aex229.", "ArticleIdList": ["10.1093/bja/aex229", "29121279"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "1", "Day": "14"}, {"Year": "2023", "Month": "3", "Day": "1"}, {"Year": "2023", "Month": "3", "Day": "7"}, {"Year": "2023", "Month": "3", "Day": "30", "Hour": "6", "Minute": "11"}, {"Year": "2023", "Month": "3", "Day": "29", "Hour": "1", "Minute": "36"}, {"Year": "2023", "Month": "3", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "9"}], "PublicationStatus": "epublish", "ArticleIdList": ["36982352", "PMC10049472", "10.3390/ijms24065279", "ijms24065279"]}}], "PubmedBookArticle": []}